A hybrid separator for an electrochemical cell is provided, along with methods of making the hybrid separator. The hybrid separator includes a first metal-organic framework comprising copper and having a plurality of first pores and a second distinct metal-organic framework comprising indium or zinc and having a plurality of second pores. The hybrid separator is capable of adsorbing one or more lithium salts in at least one of the plurality of first pores or the plurality of second pores so as to be ionically conductive. The hybrid separator may have a conductivity greater than or equal to about 0.1 mS/cm to less than or equal to about 1 mS/cm and is substantially free of any polymeric binder.

A hybrid separator for an electrochemical cell is provided, along with methods of making the hybrid separator. The hybrid separator includes a first metal-organic framework comprising copper and having a plurality of first pores and a second distinct metal-organic framework comprising indium or zinc and having a plurality of second pores. The hybrid separator is capable of adsorbing one or more lithium salts in at least one of the plurality of first pores or the plurality of second pores so as to be ionically conductive. The hybrid separator may have a conductivity greater than or equal to about 0.1 mS/cm to less than or equal to about 1 mS/cm and is substantially free of any polymeric binder.

Provided are a novel naphthalocyanine compound, which has strong absorption in a near-infrared range, extremely weak absorption in a visible range, and high resistance such as light resistance and heat resistance, and exhibits excellent solubility in an organic solvent or a resin, a heat ray shielding material, and uses of the naphthalocyanine compound such as a heat ray shielding material and the like. The naphthalocyanine compound is represented by General Formula (1). ##STR00001## wherein, in Formula (1), M represents two hydrogen atoms, a divalent metal, or a derivative of a trivalent or tetravalent metal, R.sub.1 to R.sub.3 each independently represent a hydrogen atom, a halogen atom, or a linear, branched, or cyclic alkyl group, A represents Formula (2), and B represents Formula (3), ##STR00002## wherein, in Formula (2), R.sub.4 to R.sub.8 each independently represent a hydrogen atom, a halogen atom, an alkyl group, an alkoxy group, an alkylthio group, an aryloxy group, or an arylthio group, and ##STR00003## wherein, in Formula (3), X represents an oxygen atom, a sulfur atom, and or an imino group, R.sub.9 to R.sub.13 each independently represent a hydrogen atom, a halogen atom, an alkyl group, an alkoxy group, an ester group, an amide group, or a sulfonamide group.

Provided are a novel naphthalocyanine compound, which has strong absorption in a near-infrared range, extremely weak absorption in a visible range, and high resistance such as light resistance and heat resistance, and exhibits excellent solubility in an organic solvent or a resin, a heat ray shielding material, and uses of the naphthalocyanine compound such as a heat ray shielding material and the like. The naphthalocyanine compound is represented by General Formula (1). ##STR00001## wherein, in Formula (1), M represents two hydrogen atoms, a divalent metal, or a derivative of a trivalent or tetravalent metal, R.sub.1 to R.sub.3 each independently represent a hydrogen atom, a halogen atom, or a linear, branched, or cyclic alkyl group, A represents Formula (2), and B represents Formula (3), ##STR00002## wherein, in Formula (2), R.sub.4 to R.sub.8 each independently represent a hydrogen atom, a halogen atom, an alkyl group, an alkoxy group, an alkylthio group, an aryloxy group, or an arylthio group, and ##STR00003## wherein, in Formula (3), X represents an oxygen atom, a sulfur atom, and or an imino group, R.sub.9 to R.sub.13 each independently represent a hydrogen atom, a halogen atom, an alkyl group, an alkoxy group, an ester group, an amide group, or a sulfonamide group.

Disclosed herein are composite materials that comprise one or more copper-cysteamines capable of converting higher frequency, lower wavelength radiation into visible light. As used, the produced visible light enhances the amount of visible light already present from natural or artificial sources.

Disclosed herein are composite materials that comprise one or more copper-cysteamines capable of converting higher frequency, lower wavelength radiation into visible light. As used, the produced visible light enhances the amount of visible light already present from natural or artificial sources.

Disclosed are adsorption complexes that include 1-methylcyclopropene (1-MCP) and a metal coordination polymer network (MCPN), wherein the MCPN is a porous material, and the 1-MCP is adsorbed into the MCPN. Also disclosed are kits for containing 1-MCP that include the adsorption complex in a 1-MCP-impermeable package. Also disclosed are methods of releasing 1-methylcyclopropene (1-MCP) from the kit that include the application of aqueous fluids, heat, and/or pressure.

Disclosed are adsorption complexes that include 1-methylcyclopropene (1-MCP) and a metal coordination polymer network (MCPN), wherein the MCPN is a porous material, and the 1-MCP is adsorbed into the MCPN. Also disclosed are kits for containing 1-MCP that include the adsorption complex in a 1-MCP-impermeable package. Also disclosed are methods of releasing 1-methylcyclopropene (1-MCP) from the kit that include the application of aqueous fluids, heat, and/or pressure.

The present invention relates to compounds of Formula I:

##STR00001##

wherein R.sup.1, L.sup.1, A, X.sup.a, L.sup.2, B and X.sup.b are each as defined herein. The present invention also relates to compounds of Formula II and III defined herein, formed by self-assembly of the compounds of Formula I with a metal M and an anion Q. Compounds of Formula II and III are useful in the treatment of proliferative disorders, such as cancer. The present invention also relates to pharmaceutical compositions comprising compounds of Formula I, II or III, and to the use of these compounds and compositions in the treatment of proliferative disorders, such as cancer.

The present invention relates to compounds of Formula I:

##STR00001##

wherein R.sup.1, L.sup.1, A, X.sup.a, L.sup.2, B and X.sup.b are each as defined herein. The present invention also relates to compounds of Formula II and III defined herein, formed by self-assembly of the compounds of Formula I with a metal M and an anion Q. Compounds of Formula II and III are useful in the treatment of proliferative disorders, such as cancer. The present invention also relates to pharmaceutical compositions comprising compounds of Formula I, II or III, and to the use of these compounds and compositions in the treatment of proliferative disorders, such as cancer.